Literature DB >> 1810301

Reserpine: a relic from the past or a neglected drug of the present for achieving cost containment in treating hypertension?

G J Magarian1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1810301     DOI： 10.1007/BF02598229

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  136 in total

1.  Reserpine, gastric secretion, and peptic ulcer.

Authors:  W H BACHRACH
Journal:  Am J Dig Dis       Date:  1959-02

Review 2.  Suppositions and speculations--their possible effects on treatment decisions in the management of hypertension.

Authors:  M Moser
Journal:  Am Heart J       Date:  1989-12       Impact factor: 4.749

3.  The costs of treating hypertension.

Authors:  M Moser
Journal:  Cardiovasc Drugs Ther       Date:  1989-10       Impact factor: 3.727

4.  The effect of captopril and metoprolol as monotherapy or combined with bendroflumethiazide on blood lipids.

Authors:  O P Foss; E K Jensen
Journal:  J Intern Med       Date:  1990-02       Impact factor: 8.989

5.  Reserpine and breast cancer.

Authors: 
Journal:  Lancet       Date:  1974-09-21       Impact factor: 79.321

6.  Compliance with prescribed medication by elderly patients.

Authors:  R Kendrick; J R Bayne
Journal:  Can Med Assoc J       Date:  1982-11-15       Impact factor: 8.262

7.  Effects of diuretic and beta-blocker therapy in the Medical Research Council Trial.

Authors:  G Greenberg; P J Brennan; W E Miall
Journal:  Am J Med       Date:  1984-02-27       Impact factor: 4.965

8.  Side effects of hypotensive agents evaluated by a self-administered questionnaire.

Authors:  C J Bulpitt; C T Dollery
Journal:  Br Med J       Date:  1973-09-01

9.  The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.

Authors: 
Journal:  JAMA       Date:  1984-01-20       Impact factor: 56.272

10.  Prevalence and natural history of electrocardiographic left ventricular hypertrophy.

Authors:  W B Kannel
Journal:  Am J Med       Date:  1983-09-26       Impact factor: 4.965
View more
  6 in total

Review 1.  [Reserpine-diuretic combinations in therapy of arterial hypertension. Current considerations].

Authors:  M Siepmann; W Kirch
Journal:  Med Klin (Munich)       Date:  1998-12-15

2.  Reserpine reconsidered: no association with serious peptic ulcer disease.

Authors:  R I Shorr; W A Ray; J R Daugherty; M R Griffin
Journal:  J Gen Intern Med       Date:  1993-09       Impact factor: 5.128

3.  Multiwalled Carbon Nanotubes-Dispersive Solid-Phase Extraction Coupled with UPLC-ESI-MS-MS for Simultaneous Determination of 10 Illegal Adulterants in Antihypertensive Functional Foods.

Authors:  Jielan Hu; Li Zeng; Ling He; Fan You; Chengjun Sun
Journal:  J Chromatogr Sci       Date:  2016-02-04       Impact factor: 1.618

Review 4.  Should Renal Inflammation Be Targeted While Treating Hypertension?

Authors:  Sarika Chaudhari; Grace S Pham; Calvin D Brooks; Viet Q Dinh; Cassandra M Young-Stubbs; Caroline G Shimoura; Keisa W Mathis
Journal:  Front Physiol       Date:  2022-06-13       Impact factor: 4.755

Review 5.  Drug-induced depression in the aged. What can be done?

Authors:  L Ganzini; J R Walsh; S B Millar
Journal:  Drugs Aging       Date:  1993 Mar-Apr       Impact factor: 3.923

6.  Getting to goal blood pressure: why reserpine deserves a second look.

Authors:  Joshua Barzilay; Richard Grimm; William Cushman; Alain G Bertoni; Jan Basile
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-08       Impact factor: 3.738
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.